Clinical Trial Update: A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity [Phase 2]

View source ↗

Summary

Phase 2 study comparing injection site pain for semaglutide B versus semaglutide D using two different pens in adults, including healthy volunteers and those wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight
• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide B (semaglutide)
• semaglutide D (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Healthy Volunteers Diabetes Mellitus, Type 2, Healthy Volunteers Overweight | Phase 2 | Status: COMPLETED | Results posted: 2021-01-20